— Researchers call it 'considerable improvement' on previous models
A simple clinical prediction model has been developed and validated that should help improve physicians' ability to predict which ambulatory patients with solid cancers are most at risk for venous thromboembolism (VTE) and who therefore might most benefit from thromboprophylaxis.